Literature DB >> 32935311

Prescription Opioid Dispensing Patterns Prior to Heroin Overdose in a State Medicaid Program: a Case-Control Study.

Daniel M Hartung1, Kirbee A Johnston2, Sara Hallvik3, Gillian Leichtling3, Jonah Geddes2, Christi Hildebran3, Shellie Keast4, Brian Chan5, P Todd Korthuis5.   

Abstract

BACKGROUND: A large proportion of individuals who use heroin report initiating opioid use with prescription opioids. However, patterns of prescription opioid use preceding heroin-related overdose have not been described.
OBJECTIVE: To describe prescription opioid use in the year preceding heroin overdose.
DESIGN: Case-control study comparing prescription opioid use with a heroin-involved overdose, non-heroin-involved opioid overdose, and non-overdose controls from 2015 to 2017. PARTICIPANTS: Oregon Medicaid beneficiaries with linked administrative claims, vital statistics, and prescription drug monitoring program data. MAIN MEASURES: Opioid, benzodiazepine, and other central nervous system depressant prescriptions preceding overdose; among individuals with one or more opioid prescription, we assessed morphine milligram equivalents per day, overlapping prescriptions, prescriptions from multiple prescribers, long-term use, and discontinuation of long-term use. KEY
RESULTS: We identified 1458 heroin-involved overdoses (191 fatal) and 2050 non-heroin-involved opioid overdoses (266 fatal). In the 365 days prior to their overdose, 45% of individuals with a heroin-involved overdose received at least one prescribed opioid compared with 78% of individuals who experienced a non-heroin-involved opioid overdose (p < 0.001). For both heroin- and non-heroin-involved overdose cases, the likelihood of receiving an opioid increased with age. Among heroin overdose cases with an opioid dispensed, the rate of multiple pharmacy use was the only high-risk opioid pattern that was greater than non-overdose controls (adjusted odds ratio 3.2; 95% confidence interval 1.48 to 6.95). Discontinuation of long-term opioid use was not common prior to heroin overdose and not higher than discontinuation rates among non-overdose controls.
CONCLUSIONS: Although individuals with a heroin-involved overdose were less likely to receive prescribed opioids in the year preceding their overdose relative to non-heroin opioid overdose cases, prescription opioid use was relatively common and increased with age. Discontinuation of long-term prescription opioid use was not associated with heroin-involved overdose.

Entities:  

Keywords:  heroin; overdose; prescription opioids

Mesh:

Substances:

Year:  2020        PMID: 32935311      PMCID: PMC7661590          DOI: 10.1007/s11606-020-06192-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  31 in total

1.  Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016.

Authors:  Hawre Jalal; Jeanine M Buchanich; Mark S Roberts; Lauren C Balmert; Kun Zhang; Donald S Burke
Journal:  Science       Date:  2018-09-21       Impact factor: 47.728

2.  Emergency Department Visits Involving Opioid Overdoses, U.S., 2010-2014.

Authors:  Gery P Guy; Emilia Pasalic; Kun Zhang
Journal:  Am J Prev Med       Date:  2017-11-11       Impact factor: 5.043

3.  The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis.

Authors:  Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2019-02-02

4.  Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.

Authors:  Christopher M Jones
Journal:  Drug Alcohol Depend       Date:  2013-02-12       Impact factor: 4.492

5.  No Shortcuts to Safer Opioid Prescribing.

Authors:  Deborah Dowell; Tamara Haegerich; Roger Chou
Journal:  N Engl J Med       Date:  2019-04-24       Impact factor: 91.245

6.  Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.

Authors:  Theodore J Cicero; Matthew S Ellis
Journal:  JAMA Psychiatry       Date:  2015-05       Impact factor: 21.596

7.  Mortality After Discontinuation of Primary Care-Based Chronic Opioid Therapy for Pain: a Retrospective Cohort Study.

Authors:  Jocelyn R James; JoAnna M Scott; Jared W Klein; Sara Jackson; Christy McKinney; Matthew Novack; Lisa Chew; Joseph O Merrill
Journal:  J Gen Intern Med       Date:  2019-08-29       Impact factor: 5.128

8.  Problematic use of prescription-type opioids prior to heroin use among young heroin injectors.

Authors:  Robin A Pollini; Caleb J Banta-Green; Jazmine Cuevas-Mota; Mitcheal Metzner; Eyasu Teshale; Richard S Garfein
Journal:  Subst Abuse Rehabil       Date:  2011-10

9.  Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health.

Authors:  Beth Han; Wilson M Compton; Carlos Blanco; Elizabeth Crane; Jinhee Lee; Christopher M Jones
Journal:  Ann Intern Med       Date:  2017-08-01       Impact factor: 25.391

Review 10.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

View more
  5 in total

1.  Associations of opioid prescription dose and discontinuation with risk of substance-related morbidity in long-term opioid therapy.

Authors:  Patrick D Quinn; Zheng Chang; Matthew J Bair; Martin E Rickert; Robert D Gibbons; Kurt Kroenke; Brian M D'Onofrio
Journal:  Pain       Date:  2022-04-01       Impact factor: 7.926

Review 2.  Assessing opioid overdose risk: a review of clinical prediction models utilizing patient-level data.

Authors:  Iraklis Erik Tseregounis; Stephen G Henry
Journal:  Transl Res       Date:  2021-03-21       Impact factor: 10.171

Review 3.  Mental disorder and opioid overdose: a systematic review.

Authors:  Jenna van Draanen; Christie Tsang; Sanjana Mitra; Vanessa Phuong; Arata Murakami; Mohammad Karamouzian; Lindsey Richardson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-11-18       Impact factor: 4.519

4.  Using qualitative, community-based input to steer post-coronavirus disease 2019 pharmacy practice in substance use.

Authors:  Lucas Kosobuski; Andrew Hawn; Katelyn France; Nathaniel Chen; Cierra LaPlante; Laura Palombi
Journal:  J Am Pharm Assoc (2003)       Date:  2022-03-19

5.  Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.

Authors:  Daniel M Hartung; Sheila Markwardt; Kirbee Johnston; Jonah Geddes; Robin Baker; Gillian Leichtling; Christi Hildebran; Brian Chan; Ryan R Cook; Dennis McCarty; Udi Ghitza; P Todd Korthuis
Journal:  Addict Sci Clin Pract       Date:  2022-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.